Clinical and Immunological Follow-up of Previously Hospitalized HIV-2 Seropositive Patients in Bissau, Guinea-Bissau

References

• Clavel F, Guetard D, Brun-Vezinet F, Chamaret S, Rey M-A, Santos-Ferreira M O, Laurent A G, Dauguet C, Karlama C, Rouzioux C, Klatzmann D, Champalimaud J L, Montagnier L. Isolation of a new human retrovirus from West African patients with AIDS. Science 1986; 233: 343–346
   PubMed Web of Science ®Google Scholar
• Kanki P J. West African human retroviruses related to STLV-III. AIDS 1987; 1: 141–145
   PubMed Web of Science ®Google Scholar
• Clavel F. HIV-2, the West African AIDS virus. AIDS 1987; 1: 135–140
   PubMed Web of Science ®Google Scholar
• Horsburgh CR, Jr, Holmberg S D. The global distribution of human immunodeficiency virus type 2 (HIV-2) infection. Transfusion 1988; 28: 192–195
   PubMed Web of Science ®Google Scholar
• DeCock K M, Brun-Vezinet F. Epidemiology of HIV-2 infection. AIDS 1989; 3(Suppl 1)S89–95
   Web of Science ®Google Scholar
• Romieu J, Marlink R, Kanki P, M'Boup S, Essex M. HIV-2 link to AIDS in West Africa. J AIDS 1990; 3: 220–230
   PubMed Web of Science ®Google Scholar
• Poulsen A-G, Kvinesdal B, Aaby P, Molbak K, Frederiksen K, Dias F, Lauritzen E. Prevalence of and mortality from human immunodeficiency virus type 2 in Bissau, West Africa. Lancet 1989; 1: 827–831
   PubMed Web of Science ®Google Scholar
• Nauclér A, Andreasson P-ÅCosta C M, Thorstensson R, Biberfeld G. HIV-2 associated AIDS and HIV-2 seroprevalence in Bissau, Guinea-Bissau. J AIDS 1989; 2: 88–93
   PubMed Web of Science ®Google Scholar
• Nauclér A, Albino P, DaSilva A P, Andreasson P-Å, Andersson S, Biberfeld G. HIV-2 infection in hospitalized patients in Bissau. AIDS 1991; 5: 301–304
   PubMed Web of Science ®Google Scholar
• Marlink R G, Richard D, M'Boup S, Kanki P J, Romet-Lemonne J-L, N'Doye I, Diop K, Simpson M A, Greco F, Chou M-J, Degruttola V, Hsieh C-C, Boye C, Barin F, Denis F, McLane M F, Essex M. Clinical, hematological and immunological cross-sectional evaluation of individuals exposed to human immunodeficiency virus type 2 (HIV-2). AIDS Res Hum Retroviruses 1988; 4: 137–148
   PubMed Web of Science ®Google Scholar
• Tidiane S, Thior J, Marlink R, M'Boup S, Hellinger J, Essex M, Kanki P. Clinico-immunological evaluation of HIV-2-infection in Senegal. V International Conference on AIDS in Africa, WPB7, Kinshasa, Zaire, 1990, Abstract
   Google Scholar
• Clavel F, Mansinho K, Chamaret S, Guetard D, Favier V, Nina J, Santos-Ferreira M-O, Champalimaud J-L, Montagnier L. Human immunodeficiency virus type 2 infection associated with AIDS in West Africa. N Engl J Med 1987; 316: 1180–1185
   PubMed Web of Science ®Google Scholar
• Brun-Vezinet F, Katlama C, Roulot D, Lenoble L, Alizon M, Madjar J J, Rey M A, Girard P M, Yeni P, Clavel F, Gadelle S, Harzic M. Lymphadenopathy-associated virus type 2 in AIDS and AIDS-related complex. Lancet 1987; 1: 128–132
   PubMed Web of Science ®Google Scholar
• DeCock K M, Odehouri K, Colebunders R L, Adjorlolo G, Lafontaine M-F, Porter A, Gnaore E, DiabyMoreau L., Heyward W L. A comparison of HIV-1 and HIV-2 infections in hospitalized patients in Abidjan, Cte divoire. AIDS 1990; 4: 443–448
   PubMed Web of Science ®Google Scholar
• World Health Organization. Acquired imunodeficiency syndrome (AIDS) WHO/CDC case definition for AIDS. Wkly Epidemiol Rec 1986; 61: 69–73
   Google Scholar
• Biberfeld G, Torstensson R, Bergström M, Nauclér A, Mendes Costa C. Enzyme immunoassays for the demonstration of antibodies to HIV-2 (SBL-6669) and HTLV-IV (SIVmac). AIDS 1988; 2: 195–199
   PubMed Web of Science ®Google Scholar
• Albert J, Bredberg U, Chiodi F, Böttiger B, Fenyö E-M, Norrby E, Biberfeld G. A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II and HTLV-IIIB. AIDS 1987; 3: 3–10
   Web of Science ®Google Scholar
• Zachar V, Mikulecky M, Mayer V, Mackay I, Frazer I. A biometrical view on normal values of CD4 and CD8 lymphocyte counts in peripheral blood. Pathology 1988; 20: 358–360
   PubMed Web of Science ®Google Scholar
• Masur H, Ognibene F P, Yarchoan R, Shelhamer J H, Baird B F, Travis W, Suffredini A F, Deyton L, Kovacs J A, Falloon J, Davey R, Polis M, Metcalf J, Baseler M, Wesley R, Gill V J, Fauci A S, Lane H C. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus infection. Ann Intern Med 1989; 111: 223–231
   PubMed Web of Science ®Google Scholar
• Moss A R, McCallum G, Volberding P A, Bacchetti P, Dritz S. Mortality associated with mode of presentation in the acquired immune deficiency syndrome. J Natl Cancer Inst 1984; 73: 1281–1284
   PubMedGoogle Scholar
• Friedland G H, Saltzman B, Vileno J, Freeman K, Schrager L K, Klein R S. Survival differences in patients with AIDS. J AIDS 1991; 4: 144–153
   PubMed Web of Science ®Google Scholar
• Mann J M, Colebunders R L, Khonde N, Nzilambi N, Jansegers L, McCormick J B, Quinn T C, Bila K, Kalemba K, Bosenge N, Malonga M, Francia H, Piot P, Curran J W. Natural history of human immunodeficiency virus infection in Zaire. Lancet 1986; 1: 707–709
   Google Scholar
• LeGuenno B M, Barabe P, Griffet P A, Guiraud M, Morcillo R J, Peghini M E, Jean P A, Mbaye P S, Diallo A, Sarthou J-L. HIV-2 and HIV-1 AIDS cases in Senegal: Clinical patterns and immunological perturbations. J AIDS 1991; 4: 421–427
   PubMed Web of Science ®Google Scholar
• Lisse I M, Poulsen A-G, Aaby P, Normark M, Kvinesdal B, Dias F, Molbak K, Knudsen K. Immunodeficiency in HIV-2 infection: a community study from Guinea-Bissau. AIDS 1990; 4: 1263–1266
   PubMed Web of Science ®Google Scholar
• Colebunders R L, Lebughe I, Nzila N, Kalunga D, Francis H, Ryder R, Piot P. Cutaneous delayed-type hypersensitivity in patients with human immunodeficiency virus infection in Zaire. J AIDS 1989; 2: 576–578
   PubMed Web of Science ®Google Scholar
• Lane H C, Fauci A S. Immunologic abnormalities in the acquired immunodeficiency syndrome. Annu Rev Immunol 1985; 3: 477–500
   PubMed Web of Science ®Google Scholar